Skip to main content
Log in

Secondary prevention in patients with cerebrovascular ischaemic disease

  • Satellite Symposium
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Suggested reading

  • Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patient. Antiplatelet Trialists’ Collaboration (1994). BMJ 308:81–106

    Google Scholar 

  • Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterctomy trial collaborators (1991). N Engl J Med 325:445–453.

  • Dennis M, Bamford J, Sandercock P, Warlow C (1990) Prognosis of transient ischemic attacks in the Oxfordshire community stroke project. Stroke 21:848–853.

    PubMed  CAS  Google Scholar 

  • Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association (1994). Stroke 25(6):1320–1335.

    Google Scholar 

  • Bots M, van der Wilk EC, Koudstaal PJ, Hofman A, Grobbee DE (1997) Transient neurological attacks in the general population. Prevalence risk factors and clinical relevance. Stroke 28:768–773.

    PubMed  CAS  Google Scholar 

  • Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M (1995) Stroke incidence case fatality and mortality in the WHO MONICA project. Stroke 26:361–367.

    PubMed  CAS  Google Scholar 

  • Diener H (1997) Antiplatelet drugs in secondary prevention of stroke. Neurology 49[Suppl 4]:75–81.

    Google Scholar 

  • CAPRIE Steering Committee (1996) A randomised trial of clopidogrel versus aspirin in patient at risk of ischaemic events (CAPRIE). Lancet 348:1329–39.

    Article  Google Scholar 

  • Bucher HC, Griffith LE, Guyatt GH (1998) Effect of HMGcoA reductase inhibitors on stroke. Ann Intern Med 128:89–95

    PubMed  CAS  Google Scholar 

  • Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana, F, Coccheri S (1997) Indobufen versus warfarin in the secondary prevention of major vascular events in monrheumatics atrial fibrillation. Stroke 28(5):1015–1021.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prati, P., Casaroli, M., Vinci, C. et al. Secondary prevention in patients with cerebrovascular ischaemic disease. Ital J Neuro Sci 19 (Suppl 1), S43–S47 (1998). https://doi.org/10.1007/BF00713886

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00713886

Keywords

Navigation